California: devices to be exempt from drug marketing rules?
This article was originally published in Clinica
A bill has been filed in the California state assembly that would replace a recent compliance requirement that device companies have found to be far too onerous.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.